Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez… - American journal of …, 2022 - Wiley Online Library
Multi‐agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez… - American Journal …, 2022 - einstein.elsevierpure.com
Multi-agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
CD DiNardo, CA Lachowiez, K Takahashi… - American Journal of …, 2022 - europepmc.org
Multi-agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez… - American journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Multi-agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez, K Takahashi… - American Journal of …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Multi‐agent induction chemotherapy (IC)
improves response rates in younger patients with acute myeloid leukemia (AML); however …
improves response rates in younger patients with acute myeloid leukemia (AML); however …
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez… - American Journal of …, 2022 - ohsu.elsevierpure.com
Multi-agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
CD DiNardo, CA Lachowiez… - American journal …, 2022 - mdanderson.elsevierpure.com
Multi-agent induction chemotherapy (IC) improves response rates in younger patients with
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …
acute myeloid leukemia (AML); however, relapse remains the principal cause of treatment …